Back to Journals » Reports in Medical Imaging » Volume 11

Influences of screening magnetic resonance imaging parameters on high-intensity focused ultrasound outcome for adenomyosis

Authors Duc NM, Huy HQ

Received 22 February 2018

Accepted for publication 26 March 2018

Published 18 May 2018 Volume 2018:11 Pages 9—14

DOI https://doi.org/10.2147/RMI.S166253

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Ms Justinn Cochran

Peer reviewer comments 3

Editor who approved publication: Professor Tarik Massoud


Nguyen Minh Duc, Huynh Quang Huy

Department of Radiology, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam

Abstract: Uterine adenomyosis is one of the most common benign pelvic diseases that adversely affects the quality of a woman’s life. High-intensity focused ultrasound is an effective noninvasive treatment option for symptomatic adenomyosis. Clinical studies showed that the prediction of immediate treatment outcome, defined as nonperfused volume ratio for adenomyosis, is one of the key parameters for determining the therapeutic efficacy. MRI parameters of adenomyosis in the screening phase, such as type, location, abdominal subcutaneous fat thickness, signal intensity of adenomyosis, size, number of foci inside the lesion, and perfusion, manifest the impact on nonperfused volume ratio. Therefore, in this article, we performed a literature review of the influential screening MRI parameters on the immediate high-intensity focused ultrasound outcome.

Keywords: adenomyosis, high-intensity focused ultrasound, magnetic resonance imaging, nonperfused volume ratio, treatment outcome

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]